首页> 外文期刊>Herz >Diagnostic and prognostic biomarkers in acute myocarditis : Interleukin-10.
【24h】

Diagnostic and prognostic biomarkers in acute myocarditis : Interleukin-10.

机译:急性心肌炎的诊断和预后生物标志物:白介素10。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Acute myocarditis is a major inflammatory heart disease with a variety of clinical courses from the acute to chronic phases represented by unexpected circulatory deterioration during hospitalization and progression to dilated cardiomyopathy. Predicting these disease courses is important for patient management. However, biomarkers have not been fully investigated. In addition, clinical profiles including symptoms, serological data, and electrocardiographic findings in acute myocarditis often mimic more common disorders such as coronary artery disease, which have reduced the diagnostic accuracy of acute myocarditis. These issues hamper the development of safer and earlier therapeutic interventions specific for acute myocarditis. Against this background, identifying simple prognostic and diagnostic biomarkers would contribute dramatically to the improvement in outcomes. Interleukin-10 may be a strong candidate for an excellent biomarker.
机译:急性心肌炎是一种主要的炎症性心脏病,从急性期到慢性期都有各种临床过程,以住院期间意外的循环恶化以及发展为扩张型心肌病为代表。预测这些疾病的病程对患者的治疗很重要。但是,生物标记物尚未得到充分研究。此外,急性心肌炎的临床特征包括症状,血清学数据和心电图检查结果通常模仿更常见的疾病,例如冠状动脉疾病,这降低了急性心肌炎的诊断准确性。这些问题阻碍了针对急性心肌炎的更安全,更早的治疗性干预措施的发展。在这种背景下,确定简单的预后和诊断生物标志物将显着改善结果。白介素10可能是优秀生物标志物的强力候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号